N-Methylpiperidine

N-Methylpiperidine

SCHEMBL3634083

CN1CCCCC1.Cl.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of N-Methylpiperidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
N-Methylpiperidine SCHEMBL571891 1.00
N-Methylpiperidine SCHEMBL9042504 0.96
N-Methylpiperidine SCHEMBL28226735 0.96
N-Methylpiperidine SCHEMBL31425141 0.96
N-Methylpiperidine SCHEMBL1920 0.96
N-Methyl Pyrrolidine (Nmp) SCHEMBL3633193 0.96
N-Methylpiperidine SCHEMBL6660565 0.96 HRH3 (0.37)
SCHEMBL21960469 0.96 HRH3 (0.37)
SCHEMBL12952612 0.96 HRH3 (0.37)
SCHEMBL12316976 0.96 HRH3 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155152-A2 COLOURING COMPOSITION COMPRISING AN AMINOPYRAZOLOPYRIDINE OXIDATION BASE AND EXHIBITING AN ACIDIC PH L'Oreal (FR) 2010-02-24 EP claimed
WO-2008138845-A2 COLOURING COMPOSITION COMPRISING AN AMINOPYRAZOLOPYRIDINE OXIDATION BASE AND EXHIBITING AN ACIDIC PH L'OREAL (FR) 2008-11-20 WO claimed
CN-107056681-A A kind of support method replaces the preparation method of cloth intermediate 广州白云山光华制药股份有限公司 2017-08-18 CN disclosed
EP-2155152-A2 COLOURING COMPOSITION COMPRISING AN AMINOPYRAZOLOPYRIDINE OXIDATION BASE AND EXHIBITING AN ACIDIC PH L'Oreal (FR) 2010-02-24 EP disclosed
WO-2008138845-A2 COLOURING COMPOSITION COMPRISING AN AMINOPYRAZOLOPYRIDINE OXIDATION BASE AND EXHIBITING AN ACIDIC PH L'OREAL (FR) 2008-11-20 WO disclosed
CN-1189476-C Thrombin inhibitors, their preparation and use BASF AG (DE) 2005-02-16 CN disclosed
CN-1090188-C Benzonaphthyridines as inhibitors of HIV BYK GULDEN LOMBERG CHEM FAB (DE) 2002-09-04 CN disclosed
CN-1053893-C Process for the manufacture of dicarboxamides HOFFMANN LA ROCHE (CH) 2000-06-28 CN disclosed
CN-1038839-C Process for preparation of cyclic amine compounds EISAI CO LTD (JP) 1998-06-24 CN disclosed
CN-1154114-A New thrombin inhibitors, their preparation and use BASF AG (DE) 1997-07-09 CN disclosed
CN-1034015-C Process to prepare cycloamine compounds EISAI CO LTD (JP) 1997-02-12 CN disclosed
CN-1117488-A Process for the manufacture of dicarboxamides HOFFMANN LA ROCHE (CH) 1996-02-28 CN disclosed
CN-1024547-C Preparation method of cyclic amine compound EISAI CO LTD (JP) 1994-05-18 CN disclosed
CN-1073939-A A kind of preparation method of cyclic amine compound EISAI CO LTD (JP) 1993-07-07 CN disclosed
CN-1071417-A The preparation method of cyclic amine compound EISAI CO LTD (JP) 1993-04-28 CN disclosed
CN-1019973-C Piperidine derivative and pharmaceutical composition containing the same EISAI CO LTD (JP) 1993-03-03 CN disclosed
CN-1030752-A Preparation method of cyclic amine compound EISAI CO LTD (JP) 1989-02-01 CN disclosed
CN-87100928-A Piperidine derivatives and pharmaceutical compositions thereof 1987-09-09 CN disclosed